HUB Organoids

As we wrap up an incredible AACR 2025, we couldn’t be prouder of our team and the amazing conversations we’ve had at Booth 1560. Sharing our groundbreaking advancements in patient-derived organoid technology has been a privilege, and the response from the oncology community has been inspiring. Being part of Merck KGaA, Darmstadt, Germany’s Life Science business has strengthened our mission to bring A PATIENT IN THE LAB® to life and push the boundaries of what’s possible in oncology research. Thank you to everyone who stopped by, shared insights, and joined us in shaping the future of cancer treatment. Let’s keep the momentum going! 🚀 #AACR2025 #HUBOrganoids #OncologyInnovation #PatientInTheLab #Teamwork #Collaboration #MerckLifeScience

#AACR attendees: this is for you - Visit us at booth #1560 to explore how our patient-derived organoid platform supports translational oncology, from target validation to preclinical efficacy and toxicity profiling. Let’s talk data, co-cultures, and next-gen models. #AACR2025 #OncologyResearch #PatientDerivedOrganoids #TranslationalModels #DrugDevelopment

Want to meet the innovators of the first ever patient-derived gut organoid? Join us in sunny San Diego at booth 4497 🌟 We're unveiling our latest discoveries at the poster presentation session, and we can't wait to share them with you. Want to dive deeper into our research? Prebook a meeting with our scientists here --> https://bit.ly/3XEpZRm What breakthrough are you most eager to learn about? Let us know in the comments! 👇 #organoids #patientinthelab #SanDiegoScience

✨Meet our leadership team during AACR at booth 1560✨ Stop by to learn more about our innovative solutions, including drug screening services and novel biobank development. Discover how, as part of Merck KGaA, Darmstadt, Germany’s Life Science business, we’re delivering cutting-edge advancements to reduce drug attrition and unravel disease complexity. #AACR2025 #DrugDiscovery #OrganoidTechnology #OncologyResearch #HUBOrganoids

Discover how patient-derived organoids are transforming ADC development! 📆Join us at AACR 2025 to explore our advanced ADC screening capabilities. Visit Poster 6743 on April 30, 2025, from 9:00AM to 12:00PM, to learn how our organoid technology accelerates ADC drug discovery and help select target indications and patient populations. Don’t miss this opportunity to see how our innovative solutions can support your ADC research! #AACR2025 #DrugDiscovery #ADCDevelopment #OrganoidTechnology #HUBOrganoids

🔍 Navigating the complexities of ADC drug development? Observing off-tumor toxicity before clinical trials is crucial yet challenging. Discover the power of in vitro patient-derived organoid screens to enhance human relevance and streamline your process. Curious about how this can transform your approach? Swipe to learn more and let's discuss your thoughts! #DrugDevelopment #BiotechInnovation #ClinicalTrials #PharmaResearch #Organoids

🎯Targeting the undruggable? Discover how to advance your KRAS inhibitor program with Organoids at AACR 2025. Our team will be at booth 1560 and we look forward to seeing you there. Reach out via this link to book a meeting in advance 🔗 https://bit.ly/4jay3Si 🔗 See you in Chicago! #AACR2025 #DrugDiscovery #KRAS #targetedtherapies #OrganoidTechnology #HUBOrganoids

HUB Organoids returns to AACR 2025! Come visit us at booth 1560 to explore how our cutting-edge patient-derived organoid technology is advancing drug discovery and development. Our scientists will also be presenting four posters showcasing innovative applications for organoids in oncology research. This is a great opportunity to connect with our team, discuss potential collaborations, and learn more about how HUB Organoids is reducing drug attrition and unraveling disease complexity. We look forward to meeting you there! #AACR2025 #DrugDiscovery #OrganoidTechnology #OncologyResearch #HUBOrganoids

🔗 Now On-Demand: Minimizing Oncology Drug Failure Rates with Organoid Modeling & Multi-Omic Data 🔗 Missed our webinar with Genedata on January 28? You can now watch it anytime! Discover how patient-derived organoids, combined with multi-omic data integration, are transforming drug development by improving preclinical translatability, refining patient stratification, and accelerating biomarker discovery. 🔹 Learn how organoid co-cultures model tumor-immune interactions 🔹 Explore optimal organoid applications for immunotherapy 🔹 See how multi-omic data integration streamlines insights for precision oncology 🎥 Watch now: https://bit.ly/4kBlYqI #Oncology #Organoids #DrugDiscovery #PrecisionMedicine #CancerResearch #MultiOmics

#IWD2025 | We step Forward in Solidarity On March 8, we join the global movement to #AccelerateAction for International Women's Day 2025. This year’s theme calls for swift and decisive steps towards achieving gender equality, emphasizing the urgency of breaking down systemic barriers and biases that women face in both personal and professional spheres. According to the World Economic Forum, at the current rate of progress, it will take until 2158—roughly five generations—to reach full gender parity. This highlights the need for bold action. At HUB Organoids, we are proud to champion women in science and actively work to create opportunities that empower women to thrive, lead, and innovate. We believe that accelerating gender equality in healthcare, research, and beyond is essential for the future of innovation and progress. 👉Let’s Accelerate Action together. Join us in pushing the boundaries of progress, ensuring that the path to gender parity is not a distant goal, but a shared reality we achieve today. #IWD2025 #AccelerateAction #GenderEquality #WomenInScience #InclusiveInnovation #BreakTheBias